Unknown

Dataset Information

Refining the definition of clinically important mineral and bone disorder in hemodialysis patients.


ABSTRACT:

Background

It is important to identify an easily defined subset of patients at increased risk of adverse clinical outcomes associated with mineral and bone disorder (MBD) biomarkers (parathyroid hormone, calcium and phosphate).

Methods

Observational cohort study of 26 221 prevalent hemodialysis patients in Davita clinics as of 31 August 2005 and followed up until 31 December 2006 (16 months). Predictors were 12 possible definitions of 'clinically important' MBD based on all 3 biomarkers, and 18 alternative definitions based on only 1 or 2 biomarkers. Events were death alone and a composite of cardiovascular hospitalization or death. Excess events were calculated based on a multivariate Cox model using 5224 patients in target for all MBD biomarkers and applied to 20 997 patie

SUBMITTER: Danese MD 

PROVIDER: S-EPMC4513894 | biostudies-literature | 2015 Aug

REPOSITORIES: biostudies-literature